HETEROGENEITY IN THE IN-VITRO SURVIVAL AND PROLIFERATION OF HUMAN SEMINOMA CELLS

被引:20
|
作者
OLIE, RA
LOOIJENGA, LHJ
DEKKER, MC
DEJONG, FH
VANDISSELEMILIANI, F
DEROOIJ, DG
VANDERHOLT, B
OOSTERHUIS, JW
机构
[1] ERASMUS UNIV ROTTERDAM,DEPT ENDOCRINOL & REPROD,3000 DR ROTTERDAM,NETHERLANDS
[2] UNIV UTRECHT,DEPT CELL BIOL,UTRECHT,NETHERLANDS
[3] DR DANIEL DEN HOED CANC CTR,DEPT STAT,3008 AE ROTTERDAM,NETHERLANDS
关键词
HUMAN SEMINOMA; IN VITRO CULTURE; PROLIFERATION; GROWTH FACTORS;
D O I
10.1038/bjc.1995.4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The in vitro culture conditions allowing survival and initial proliferation of murine primordial germ cells from 10.5 days post coitum embryos, which include the use of a murine embryonal fibroblast (STO) feeder, were applied to 21 human seminomas, composed of tumour cells which are considered as the malignant counterparts of human primordial germ cells. Cells from 18 seminomas attached poorly to STO, and only a few survived through day 10. In contrast, three seminomas showed a higher degree of attachment. Two of them showed initial proliferation and enhanced survival: 30 days for tumour SE1 and 25 days for tumour SE3. Tumour SEI was more extensively studied, using the culture conditions allowing the derivation of pluripotent embryonic stem cells from 8.5 days post coitum murine primordial germ cells, which include the use of STO feeder, stem cell factor, leukaemia inhibitory factor and basic fibroblast growth factor. The presence of stem cell factor was necessary and sufficient for colonies of tumour cells to form during the first 3 days of culture. While the cell number decreased after day 3 in medium without fetal calf serum, it increased until day 9 in medium containing fetal calf serum. No reprogramming of SE1 cells to pluripotent stem cells was observed. Our data indicate that seminomas form a tumour population with a heterogeneous in vitro behaviour not equivalent to that of 8.5-10.5 days post coitum murine primordial germ cells.
引用
收藏
页码:13 / 17
页数:5
相关论文
共 50 条
  • [21] SURVIVAL AND GONADOTROPHIN RESPONSIVENESS OF LUTEAL CELLS IN-VITRO
    HANSEL, W
    ACTA ENDOCRINOLOGICA, 1971, : 295 - +
  • [22] METHODS IN LABORATORY INVESTIGATION - NORMAL HUMAN UROTHELIAL CELLS IN-VITRO - PROLIFERATION AND INDUCTION OF STRATIFICATION
    SOUTHGATE, J
    HUTTON, KAR
    THOMAS, DFM
    TREJDOSIEWICZ, LK
    LABORATORY INVESTIGATION, 1994, 71 (04) : 583 - 594
  • [23] GANGLIOSIDES MODULATE PROLIFERATION, MIGRATION, AND INVASIVENESS OF HUMAN BRAIN-TUMOR CELLS IN-VITRO
    MERZAK, A
    KOOCHEKPOUR, S
    MCCREA, S
    ROXANIS, Y
    PILKINGTON, GJ
    MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1995, 24 (2-3) : 121 - 135
  • [24] IN-VITRO PROLIFERATION AND DIFFERENTIATION OF HUMAN CD34+ CELLS INTO NEUTROPHIL PROGENITORS AND MEGAKARYOCYTES
    LOUDOVARIS, M
    QIAO, X
    SMITH, S
    UNVERZAGT, K
    HAZELTON, B
    SCHWARTZBERG, L
    BENDER, JG
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 817 - 817
  • [25] RELATIONSHIP BETWEEN PUTRESCINE AND PROLIFERATION OF HUMAN FIBROBLASTS IN-VITRO
    POHJANPELTO, P
    EXPERIMENTAL CELL RESEARCH, 1973, 80 (01) : 137 - 142
  • [26] CYCLOSPORINE-A AND NORMAL HUMAN OSTEOBLASTS PROLIFERATION IN-VITRO
    NACHER, M
    AUBIA, J
    SERRANO, S
    MARINOSO, MLI
    DIEZ, A
    CALCIFIED TISSUE INTERNATIONAL, 1994, 54 (05) : 438 - 438
  • [27] Purified human recombinant Sulfatase 2 inhibits human breast cancer cells proliferation and invasion in-vitro
    Iskenderian, Andrea
    Romashko, Alla
    Nguyen, Duc
    Cook, Lynette
    Norton, Angela
    Gomez-Yafal, Alicia
    Heartlein, Michael
    Concino, Michael
    Martini, Paolo
    CANCER RESEARCH, 2009, 69
  • [28] AUTORADIOGRAPHIC STUDY OF PROLIFERATION AND DIFFERENTIATION OF GLIAL CELLS IN-VITRO
    MANUELIDIS, L
    MANUELIDIS, EE
    ACTA NEUROPATHOLOGICA, 1971, 18 (03) : 193 - +
  • [29] CYTOPHAGOCYTOSIS BY HUMAN TUMOR CELLS IN-VITRO
    IOACHIM, HL
    IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION, 1970, 6 (03): : 234 - &
  • [30] HEPATOCYTE PROLIFERATION IN-VITRO
    MULLERTEGETHOFF, K
    GURTLER, R
    KASPER, P
    HAMBACH, P
    SCHLEICHER, R
    MULLER, L
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1995, 14 (01) : 53 - 54